JP2020524179A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020524179A5 JP2020524179A5 JP2020519007A JP2020519007A JP2020524179A5 JP 2020524179 A5 JP2020524179 A5 JP 2020524179A5 JP 2020519007 A JP2020519007 A JP 2020519007A JP 2020519007 A JP2020519007 A JP 2020519007A JP 2020524179 A5 JP2020524179 A5 JP 2020524179A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- composition according
- mesenchymal stem
- administered
- stem cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 40
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims 14
- 230000003247 decreasing effect Effects 0.000 claims 4
- 230000001568 sexual effect Effects 0.000 claims 4
- 201000001880 Sexual dysfunction Diseases 0.000 claims 3
- 231100000872 sexual dysfunction Toxicity 0.000 claims 3
- 206010058359 Hypogonadism Diseases 0.000 claims 2
- 208000006262 Psychological Sexual Dysfunctions Diseases 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 210000002950 fibroblast Anatomy 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 210000000130 stem cell Anatomy 0.000 claims 2
- 238000011282 treatment Methods 0.000 claims 2
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims 1
- 208000030663 Libido disease Diseases 0.000 claims 1
- 206010024421 Libido increased Diseases 0.000 claims 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims 1
- 230000000735 allogeneic effect Effects 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 230000001965 increasing effect Effects 0.000 claims 1
- 238000012153 long-term therapy Methods 0.000 claims 1
- 238000012154 short term therapy Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762521765P | 2017-06-19 | 2017-06-19 | |
| US62/521,765 | 2017-06-19 | ||
| PCT/US2018/037725 WO2018236680A1 (en) | 2017-06-19 | 2018-06-15 | TREATMENT OF SEXUAL DYSFUNCTION AND IMPROVEMENT OF THE QUALITY OF SEXUAL LIFE |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020524179A JP2020524179A (ja) | 2020-08-13 |
| JP2020524179A5 true JP2020524179A5 (https=) | 2021-07-29 |
| JP7343123B2 JP7343123B2 (ja) | 2023-09-12 |
Family
ID=62952383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020519007A Active JP7343123B2 (ja) | 2017-06-19 | 2018-06-15 | 性機能低下の治療及び性的な生活の質の向上 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12496316B2 (https=) |
| EP (1) | EP3641793A1 (https=) |
| JP (1) | JP7343123B2 (https=) |
| KR (1) | KR20200017516A (https=) |
| CN (1) | CN111107858A (https=) |
| AU (1) | AU2018288653A1 (https=) |
| CA (1) | CA3067354A1 (https=) |
| IL (1) | IL271395A (https=) |
| SG (1) | SG11201912209UA (https=) |
| TW (1) | TW201919664A (https=) |
| WO (1) | WO2018236680A1 (https=) |
| ZA (1) | ZA201908451B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023540096A (ja) | 2020-09-08 | 2023-09-21 | ロングエバーオン インコーポレイテッド | アロジェニック間葉系幹細胞によるアルツハイマー病の治療 |
| CN117999082A (zh) | 2021-07-26 | 2024-05-07 | 美商生命科学有限公司 | 间充质干细胞在治疗青少年左心发育不良综合征中的用途 |
| AU2022343620A1 (en) | 2021-09-10 | 2024-01-18 | Longeveron Inc. | Treatment of aging frailty comprising administering bone marrow derived mesenchymal stem cells |
| KR102762783B1 (ko) * | 2022-01-21 | 2025-02-05 | 고현서 | 심리 프로파일에 따른 행동 습관 제공 방법, 서버, 저장 매체 및 디바이스 |
| WO2025137077A1 (en) | 2023-12-19 | 2025-06-26 | Longeveron, Inc. | Improved brain architecture and biomarkers in alzheimer's disease with mesenchymal stem cells |
| WO2025199451A2 (en) | 2024-03-21 | 2025-09-25 | Longeveron Inc. | Mmp-14 potency assay for mesenchymal stem cells |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL120266A (en) | 1996-02-28 | 2005-05-17 | Pfizer | Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions |
| WO2007149548A2 (en) * | 2006-06-22 | 2007-12-27 | Medistem Laboratories, Inc. | Treatment of erectile dysfunction by stem cell therapy |
| WO2010021996A1 (en) * | 2008-08-18 | 2010-02-25 | Junta De Beneficiencia De Guayaquil | Treatment of injuries to the central nervous system |
| US8808688B2 (en) * | 2009-10-06 | 2014-08-19 | National University Corporation Nagoya University | Cell preparation for erectile dysfunction or sensory disorders of the lower urinary tract containing adipose tissue derived mesenchymal stem cells |
| WO2013173694A2 (en) * | 2012-05-18 | 2013-11-21 | The Cooper Health System | A method of restoring endothelial/smooth muscle architecture and cell signaling pathways to sexual organs |
| EA202190962A2 (ru) * | 2014-05-30 | 2022-02-28 | Оникс Терапьютикс, Инк. | Уровни экспрессии иммуноглобулинов в качестве биологического маркера для реакции на ингибитор протеасом |
| CN105055450A (zh) * | 2015-02-13 | 2015-11-18 | 中国福利会国际和平妇幼保健院 | 人宫内膜干细胞在制备治疗卵巢早衰的药物中的应用 |
-
2018
- 2018-06-15 EP EP18742863.6A patent/EP3641793A1/en active Pending
- 2018-06-15 SG SG11201912209UA patent/SG11201912209UA/en unknown
- 2018-06-15 US US16/624,118 patent/US12496316B2/en active Active
- 2018-06-15 WO PCT/US2018/037725 patent/WO2018236680A1/en not_active Ceased
- 2018-06-15 CA CA3067354A patent/CA3067354A1/en active Pending
- 2018-06-15 AU AU2018288653A patent/AU2018288653A1/en not_active Abandoned
- 2018-06-15 CN CN201880046823.4A patent/CN111107858A/zh active Pending
- 2018-06-15 JP JP2020519007A patent/JP7343123B2/ja active Active
- 2018-06-15 KR KR1020207001647A patent/KR20200017516A/ko not_active Withdrawn
- 2018-06-19 TW TW107120931A patent/TW201919664A/zh unknown
-
2019
- 2019-12-12 IL IL271395A patent/IL271395A/en unknown
- 2019-12-18 ZA ZA2019/08451A patent/ZA201908451B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020524179A5 (https=) | ||
| MX2025005489A (es) | Uso de lumateperona para el tratamiento del trastorno bipolar ii | |
| CA2747794A1 (en) | Treatment of lung and pulmonary diseases and disorders | |
| RU2013108248A (ru) | Иммуногенные противовоспалительные композиции | |
| CO6630139A2 (es) | Aptámeros par b-bgf y su uso en el tratamiento de enfermedades y transtornos mediados por b-ngf | |
| MX375745B (es) | Composicion para el tratamiento de la diabetes que comprende conjugado de analogo de insulina de accion prolongada y conjugado de peptido insulinotropico de accion prolongada. | |
| MX2015005148A (es) | Formas il-15r alfa, celulas que expresan las formas de il-15 alfa, y usos terapeuticos de il-15r alfa y complejos il-15/il-15r. | |
| MX2022013590A (es) | Metodos y composiciones para el tratamiento de trastorno por deficit de atencion. | |
| MX390627B (es) | Uso de pridopidina para el tratamiento de la disminucion funcional. | |
| JP2009545620A5 (https=) | ||
| NZ578928A (en) | Methods to increase mobility of hematopoietic stem cells by use of a lipopeptide compound and treatment of associated diseases | |
| ECSP20082338A (es) | Receptores del factor de crecimiento quimérico | |
| JP2016530284A5 (https=) | ||
| EA201492010A1 (ru) | Применение высокой дозы лахинимода для лечения рассеянного склероза | |
| NZ758331A (en) | B cells for in vivo delivery of therapeutic agents and dosages thereof | |
| MX2020012077A (es) | Composiciones y metodos para el tratamiento de la enfermedad de parkinson. | |
| NZ595046A (en) | Compositions and methods for extended therapy with aminopyridines | |
| CO6771406A2 (es) | Una composición combinada | |
| MX376783B (es) | Liposomas que encapsulan un autoantígeno y su uso en la prevención y/o el tratamiento de enfermedades autoinmunes. | |
| CO7170176A2 (es) | Nuevo compuesto que tiene la capacidad para inhibir la enzima deshidrogenasa11b-hidroxiesteroide tipo 1(11b-hsd1) o sal farmaceúticamente aceptable del mismo, método para producir el mismo, y composición farmaceútica que contiene el mismo como ingrediente activo | |
| MX2012001853A (es) | Composicion farmaceutica para aliviar el dolor. | |
| SG194753A1 (en) | Induction of il-12 using immunotherapy | |
| AR082501A1 (es) | Usos terapeuticos de 1-[2-(2,4-dimetil-fenilsulfanil)fenil]piperazina | |
| MY195178A (en) | Composition for Treating Joint Disease and Kit Containing Same | |
| MX374938B (es) | Un método para el tratamiento de trastornos del movimiento con befiradol. |